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A large gap exists in our understanding of the course
of differentiation from mesoderm to definitive he-
matopoietic stem cells (HSCs). Previously, we re-
ported that Runx1+ cells in embryonic day 7.5 (E7.5)
embryos contribute to the hemogenic endothelium
in the E10.5 aorta-gonad-mesonephros (AGM) region
and HSCs in the adult bone marrow. Here, we show
that two Runx1+ populations subdivided by Gata1
expression exist in E7.5 embryos. The hemogenic
endothelium and the HSCs are derived only from
the Runx1+Gata1 population. A subset of this pop-
ulation moves from the extra- to intraembryonic
region during E7.5–E8.0, where it contributes to the
hemogenic endothelium of the dorsal aorta (DA).
Migration occurs before the heartbeat is initiated,
and it is independent of circulation. This suggests a
developmental trajectory from Runx1+ cells in the
E7.5 extraembryonic region to definitive HSCs via
the hemogenic endothelium.INTRODUCTION
How definitive hematopoietic stem cells (HSCs) emerge is a
major unresolved issue in hematology. For more than three de-
cades, researchers have repeatedly addressed this question
using different technologies. The consensus can be summa-
rized in two points: (1) the earliest blood cell (BC) formation
occurs in the extraembryonic region, and (2) the first definitive
HSCs that contribute to adult hematopoiesis appearing in theembryo proper and placenta most likely differentiate directly
from endothelial cells (ECs) (Cai et al., 2000; Chen et al.,
2011; Medvinsky and Dzierzak, 1996; Medvinsky et al., 2011;
Ottersbach and Dzierzak, 2005; Rhodes et al., 2008; Zovein
et al., 2010). The major point of contention has been how
these two events, which occur at different embryonic sites,
are related. However, because of a lack of knowledge con-
cerning the differentiation of hemogenic ECs from mesoderm,
the answers proposed for this question so far have been
ambiguous.
Null mutations in either the Flk1 or Etv2/ER71 gene result in a
lack of both ECs and BCs during embryogenesis, and Etv2 null
embryos completely lack Flk1+ mesoderm distributed over
extraembryonic space, which is also Etv2+ in normal embryos
(Kataoka et al., 2011; Koyano-Nakagawa et al., 2012; Lee
et al., 2008; Shalaby et al., 1995, 1997). Thus, the Flk1+Etv2+
mesoderm is the latest point from which the progenitors of
all ECs and BCs are segregated from other lineages. Some of
these precursors migrate into the intraembryonic region and
form intraembryonic vasculature, including the dorsal aorta
(DA), as angioblasts (Cleaver and Krieg, 1998; Shalaby et al.,
1997; Drake and Fleming, 2000). Gata1 is a key regulator of
erythroid gene transcription and a primitive erythrocyte progen-
itor marker, and is expressed in blood islands (BIs) at the onset
of primitive erythropoiesis (Fujiwara et al., 1996; Onodera et al.,
1997; Silver and Palis, 1997). Runx1 is an essential transcrip-
tional factor of definitive hematopoiesis (Okuda et al., 1996;
Wang et al., 1996) and plays an important role in the generation
of HSCs from hemogenic endothelium (North et al., 1999). We
previously showed that embryonic day 7.5 (E7.5) Runx1+ cells
contribute to HSCs and this Runx1 expression is required
for the later emergence of HSCs (Samokhvalov et al., 2007;
Tanaka et al., 2012). In this study, we used lineage-tracing
analysis and time-lapse live imaging to examine how E7.5Cell Reports 8, 31–39, July 10, 2014 ª2014 The Authors 31
Runx1+ cells contribute to HSCs. Our findings suggest a
possible origin of HSCs.
RESULTS
Runx1+ Cells Are Derived from Flk1+Etv2+ Cells in E7.5
Embryos
To further understand the contribution of E7.5 Runx1+ cells to
definitive hematopoiesis, we first had to determinewhich Runx1+
cells contribute to HSC formation. Runx1 expression is detected
in the hematopoietic and vascular components of BIs, chorionic
mesoderm, allantois, and yolk sac (YS) visceral endoderm at
E7.5 (Daane and Downs, 2011; Iacovino et al., 2011; Lacaud
et al., 2002; North et al., 1999; Zeigler et al., 2006) (Figure S1A).
At E7.5, almost all Flk1+ cells express Etv2 (Figure S1B). Given
that all BCs and ECs come fromFlk1+Etv2+ cells at this time point
(Kataoka et al., 2011; Koyano-Nakagawa et al., 2012; Lee et al.,
2008), E7.5 Runx1+ cells that contribute to definitive hema-
topoiesis should be derived from Flk1+ cells in the embryo.
In Runx1IRESGFP/+ embryos, most GFP+ cells (Runx1+ cells) at
the midstreak stage were Flk1+ but started to lose Flk1 expres-
sion by the late-streak stage, suggesting that Runx1+ cells
appear from theFlk1+populationduringdevelopment (Figure1A).
We also confirmed that Runx1+ cells were detected within the
Etv2+ cell population in Etv2Venus/+ embryos at both the neural-
plate (NP) and head-fold (HF) stages (Figures 1B and S1C).
Furthermore, no Runx1 expression was detected in Etv2 null em-
bryos at E7.5 and E8.5 (Figure S1D). Thus, the E7.5 Runx1+ cells
that contribute to HSCs are derived from Flk1+Etv2+ mesoderm.
Runx1+Gata1 Cells in E7.5 Embryos
Are Angioblast-Like Cells
Most Runx1+ cells in the BIs expressed Gata1, but a few
Runx1+Gata1 cells were detected in the periphery of the BIs
at E7.5 (Figures 1B). Cryosections showed that Runx1+Gata1+
cells were detected only in the BIs, whereas a few Runx1+
Gata1 cells were detected in the base of the allantois, amniotic
mesoderm, and chorionic mesoderm (Figures S1A and S1C). In
order to examine the expression pattern of Runx1 and Gata1 at
the single-cell level, we generated a mouse strain that carried
two fluorescent markers: GFP in a Runx1 allele and mCherry in
a Gata1 allele (Figure S1E). Flow cytometric analysis showed
that nearly all of the Gata1+ (mCherry+) cells coexpressed
Runx1 (GFP). Although the majority of Runx1+ cells expressed
Gata1, a significant number of Runx1+Gata1 cells were present
(16% and 5.7% of Runx1+ cells were Gata1 at the NP and HF
stages, respectively; Figure 1C). Within the Flk1+ population,
75.5% and 85.2% of Runx1+ cells were Gata1 at the NP and
HF stages, respectively, suggesting that the majority maintained
endothelial identity. Indeed, Runx1+Gata1 cells were distinct
from theGata1+Runx1+ population, displaying higher expression
of endothelial markers such as Flk1, Pecam1, Tie2, VE-cadherin,
and Endoglin (Figure 1D and S1F). Furthermore, hematopoietic
colony-forming potential was detected only in the Runx1+Flk1+
cells at E7.5 (Figure S1G). These data suggested that Runx1+
Gata1Flk1+ cells contribute to definitive hematopoiesis. Given
their location outside of the BIs, this cell population should be
a subset of angioblasts.32 Cell Reports 8, 31–39, July 10, 2014 ª2014 The AuthorsFate Analysis of Runx1+ and Gata1+ Populations in E7.5
Embryos
To determine whether Runx1+Gata1 cells contributed to HSCs,
we generated a mouse strain that carried Mer-Cre-Mer in a
Gata1 allele (Figures S2A and S2B). We compared the contribu-
tion of E7.5Gata1+ cells to HSCs andmajor hemogenic sites with
that of E7.5 Runx1+ cells. The progeny of E7.5 Gata1+ cells
contributed to BCs in the BIs and circulation at E8.5 and E9.5,
respectively (Figure S2C). The labeled cells were only in the YS
at E8.5 and were CD41+VE-cadherin– (Figure S2D). These are
likely to be primitive erythrocyte progenitors, not erythroid/
myeloid progenitors (EMPs), because EMPs emerge from the
YS hemogenic endothelium and should express VE-cadherin
at E8.25 (Chen et al., 2011; McGrath et al., 2011). In the E13.5
fetal liver (FL), the labeled cells expressed TER119, but not
CD45. However, the majority of TER119+ cells were eYFP, sug-
gesting that the labeled cells did not contribute to definitive
erythropoiesis (Figure S2E). The labeled cells were almost
completely lost by E16.5 in the FL and could hardly be detected
in peripheral blood from 4-week-old mice (Figure S2F). Whole-
mount immunostaining for eYFP and CD31 showed that no
marked cells were found in any endothelium at major hemogenic
sites such as the aorta-gonad-mesonephros (AGM), YS umbili-
cal artery (UA), and vitellin artery (VA) at E10.5 (Figures 2A and
2B). Taken together, these results led us to conclude that E7.5
Gata1+ cells do not contribute to HSCs or ECs.
By contrast, E7.5 Runx1+ cells contributed to definitive hema-
topoiesis by E16.5 (Figure S2G). In addition to BCs, labeled ECs
were found not only on the ventral side but also on the dorsal side
of the DA at E10.5 (Figure 2A). Whole-mount immunostaining
for CD31 and eYFP clearly showed that eYFP+ cells contributed
to endothelial cells in the DA (Figure 2C). The eYFP+ ECs were
also detected in the YS, UA, VA, and placenta (Figure 2D). Label-
ing of E7.5 Runx1+ cells also marked VE-cadherin+ cells of the
YS at E8.5, suggesting that E7.5 Runx1+ cells contribute to the
EMPs (Figure S2G). Surprisingly, a few eYFP+VE-cadherin+ cells
were detected in E8.25 caudal halves (CHs). Because labeling of
Gata1+ cells failed to mark either ECs or HSCs, we conclude that
ECs and HSCs marked by the labeling of E7.5 Runx1+ cells are
derived from the E7.5 Runx1+Gata1 population.
The Progeny of E7.5 Runx1+Gata1 Cells within
the Intraembryonic Region Originate from the
Extraembryonic Region prior to Circulation
We next examined how E7.5 Runx1+Gata1 cells contribute
to HSCs. We have previously suggested that E7.5 Runx1+
cells may stay in the YS until circulation starts and then move
to intraembryonic HSC emergence sites by the circulation (Sa-
mokhvalov et al., 2007; Tanaka et al., 2012). An alternative pos-
sibility is that E7.5 Runx1+Gata1 extraembryonic cells migrate
directly to the intraembryonic sites in the samemanner as angio-
blasts (Drake and Fleming, 2000; Shalaby et al., 1997). To inves-
tigate this further, we studied the distribution of the progeny of
E7.5 Runx1+Gata1 cells in the E8.25 embryo, the time point
at which aortic primordia and lateral vascular networks start to
form and the first intraembryonic lymphohematopoietic potential
is detected (Cumano et al., 1996). Whole-mount X-gal staining
of E8.25 Runx1SACre/+::R26RLacZ/+ embryos labeled at E7.5
Figure 1. Two Runx1+ Populations Exist in the E7.5 Extraembryonic Region
(A) Flow cytometric analysis of Runx1IRESGFP/+ embryos for Flk1 and Runx1. MS, midstreak stage; LS, late-streak stage.
(B) Whole-mount immunostaining of E7.5 Etv2Venus/+ embryos for Gata1 (cyan), Runx1 (magenta), and Venus (green) at the designated stages. Arrows in the
bottom pictures indicate single Runx1+ cells. Bottompanels show higher-magnification images of the Bl regions in the upper panels. BI, blood islands. Scale bars,
50 mm.
(C) Flowcytometric analysis ofRunx1IRESGFP/+::Gata1mCherry/Yembryosat thedesignated stages forRunx1andGata1.NP, neural-plate stage;HF, head-fold stage.
(D) Flow cytometric analysis of E7.5 Runx1IRESGFP/+::Gata1mCherry/Y embryos for Flk1, VE-cadherin, and CD31. Red lines indicate Runx1+Gata1 cells, blue lines
indicate Runx1+Gata1+ cells, and gray lines indicate Runx1Gata1 cells as negative controls.
See also Figure S1.showed that although the majority of the labeled cells were de-
tected in the BIs, a few were located within the intraembryonic
region. By contrast, Gata1IRESMCM/+::R26RLacZ/+ embryos con-
tained labeled cells only in the BIs (Figure 3 and S3A), consistent
with flow cytometric analysis of E8.5 embryos (Figures S2D and
S2G). Thus, the labeled cells detected in the intraembryonic
region in Figures 3A–3D must be the progeny of the E7.5
Runx1+Gata1 cells. Whole-mount X-gal staining of stage-matched Runx1LacZ/+ embryos showed that there were no
LacZ+ cells in the intraembryonic region, consistent with previ-
ous studies that showed that Runx1 remains undetectable in
the embryo proper until E8.25 (4–7 somite pairs [sp] stage)
(Iacovino et al., 2011; North et al., 1999; Zeigler et al., 2006).
Runx1 expression in the embryo proper became detectable at
E9.0 in the posterior vascular complex, including the DA (Fig-
ure S3B). We also examined the possibility that misexpressionCell Reports 8, 31–39, July 10, 2014 ª2014 The Authors 33
Figure 2. E7.5 Runx1+Gata1 Cells Con-
tribute to Endothelium at Major Hemogenic
Sites
(A) Whole-mount X-gal staining of E10.5 em-
bryos (labeled at E7.5) of two genotypes,
Gata1IRESMCM/X::R26RLacZ/+ and Runx1SACre/+::
R26RLacZ/+, and cryosections of their AGM region.
(B–D) Confocal images for eYFP (green) and
CD31 (magenta) expression in major hemogenic
sites of E10.5 embryos (labeled at E7.5) of two
genotypes, Gata1IRESMCM/X::R26ReYFP/+ (B) and
Runx1SACre/+::R26ReYFP/+ (C and D). Higher-
magnification images of the white-dotted boxes in
the upper-left images are shown at the bottom of
the original pictures (C). Arrows indicate eYFP+
endothelium. DA, dorsal aorta; YS, yolk sac; UA,
umbilical artery; VA, vitellin artery. Scale bars,
100 mm (original images) and 20 mm (higher-
magnification images).
See also Figure S2.of Mer-Cre-Mer resulted in labeling of cells without Runx1. How-
ever, the Mer-Cre-Mer expression pattern in E7.5 Runx1SACre/+
embryos was comparable to that of Runx1 at E7.5 (Figure S3C).
Taken together, these observations strongly suggest that the
progeny of the E7.5 Runx1+Gata1 cells within the intraem-
bryonic region at E8.25 were not labeled at this site. Because
Runx1 expression is restricted to the extraembryonic region at
E7.5, we conclude that E7.5 Runx1+Gata1 cells directly
migrated from extra- to intraembryonic sites.
Contribution of E7.5 Runx1+ Cells to the Endothelial
Layer of the DA
In order to directly examine how E7.5 Runx1+Gata1 cells
migrate, we performed a time-lapse live imaging analysis of the
progeny of E7.5 Runx1+ cells fromE7.5 to E8.5, during DA forma-
tion. We first examined how E7.5 Flk1+ angioblasts migrate,
because E7.5 Runx1+Gata1 cells are angioblast-like cells. In
E7.5 Flk1GFP/+ embryos, GFP+ cells (Flk1+ cells) were located in
the extraembryonic region (Movie S1; Figure 4A) as previously re-
ported (Ema et al., 2006). Most of GFP+ cells (Flk1+ cells) spread
over the extraembryonic region and then formed YS vascula-
tures. Only GFP+ cells (Flk1+ cells) in the boundary between the
extra- and intraembryonic regions actively migrated into the in-
traembryonic region and finally formed the paired DAs (Movie
S1; Figure 4A; V.S. and Y.Y., unpublished data). GFP+ cells34 Cell Reports 8, 31–39, July 10, 2014 ª2014 The Authors(Flk1+ cells) in and around the BIs did not
move as much. Consistent with this, in
Runx1IRESGFP/+ embryos, no GFP+ cells
(Runx1+ cells) migrated to the intraem-
bryonic region. Most were detected in
the BIs and remained localized at this re-
gion (Movie S2; Figure 4B). A few GFP+
cells (Runx1+ cells) were transiently de-
tected in the periphery of the BIs, which
could represent the Runx1+Gata1 cells.
In order to track the progeny of E7.5
Runx1+ cells, we collected Runx1SACre/+::R26ReYFP/+ embryos 8 hr after 4OHT injection (at E7.5), the time
point at which eYFP+ cells (the progeny of E7.5 Runx1+ cells)
were first detected (Figures 4C–4E), and placed them into
whole-embryo cultures for time-lapse live imaging (Figures S4A
and S4B). Our definition of the extra- and intraembryonic regions
and their boundary is shown in Figure S4C. Imaging focusing on
the intraembryonic region showed no eYFP+ cells (Figure 4C),
whereas imaging focusing on the extraembryonic region showed
eYFP+ cells in the BIs and distal extraembryonic region (Figures
4D and 4E). At time 0:00 (T0) (late-HF stage, E7.75–E8.0),
eYFP+ cells were detected in the BIs and near the boundary
(Movie S3; Figure 4E). Although eYFP+ cells in the BIs did not
move from this area, eYFP+ cells near the boundary migrated to
the intraembryonic region and then formed the endothelial layer
of the DA (Movie S3; Figure 4E). Cell-tracking analysis also iden-
tifiedmore dynamic movement of eYFP+ cells near the boundary
than in the BIs (Figure S4D). This migration pattern was similar to
that of the Flk1-GFP+ cells (Movie S1). Given that Runx1 was not
expressed in the boundary at E8.0, it is likely that the eYFP+ cells
detected there were labeled at Runx1-expressing sites such as
the periphery of the BIs, allantois, and amnion at E7.5 (but not
within theBIs), and thenmigrated into theboundary during induc-
tion of 4OHT. These data strongly suggest that the progeny of
E7.5 Runx1+ cells in the E8.25 intraembryonic region indeed
migrated from the extraembryonic region.
Figure 3. The Progeny of E7.5 Runx1+
Gata1 Cells Are Detected in the Intraem-
bryonic Region prior to Circulation
(A–L) Whole-mount X-gal staining of E8.0
embryos of three genotypes: (A–D) E8.0
Runx1SACre/+::R26RLacZ/+ labeled at E7.5, (E–H)
E8.0 Gata1IRESMCM/X::R26RLacZ/+ labeled at E7.5,
and (I–L) E8.0 Runx1LacZ/+. Scale bars, 100 mm.
See also Figure S3.The Intraembryonic Progeny of E7.5 Runx1+ Cells
Express Endothelial Markers and Have Hemogenic
Potential
Wenext investigatedwhether themigrating cells specifically con-
tributed to the endothelium of the DA in E8.25 embryos. Whole-
mount immunostaining of CD31, and eYFP in Runx1SACre/+::
R26ReYFP/+ embryos from the ex vivo culture after 4OHT induc-
tion showed that eYFP+ cells in the DA expressed CD31, but
not Runx1, suggesting that Runx1 expression in E7.5 Runx1+
Gata1 cells was lost during the migration (Figure 5A). Cryosec-
tions of E8.25 Runx1SACre/+::R26RLacZ/+ and Runx1SACre/+::
R26ReYFP/+ embryos after E7.5 4OHT induction also showed
that the progeny of the E7.5 Runx1+ cells contributed to the
VE-cadherin+ endothelial layer in the DA (Figures 5B and 5C),
consistent with the flow cytometric analysis (Figure 3D) and the
time-lapse imaging data. Some eYFP+ cells were also detected
in nonhemogenic tissues, such as the hindgut epithelium and
paraxial mesoderm. Taken together, these results indicate that
at least some E7.5 Runx1+Gata1 cells enter into the embryo
proper before the onset of circulation and contribute to the EC
layers of the DA.
To examine whether these migrating cells have hemogenic
potential, we cultured eYFP+VE-cadherin+ cells from the CHs
of E8.25 Runx1SACre/+::R26ReYFP/+ embryos after E7.5 4OHT
induction together with other three populations on OP9 cells
in the presence of interleukin-7 (IL-7) and Flt3L (Figure S5A).
Although no lymphoid cells were generated from the four pop-
ulations in this culture condition, hematopoietic colonies were
only detected from the two VE-cadherin+ populations. Of
note, a higher hematopoietic colony-forming potential was de-
tected in the eYFP+VE-cadherin+ population (about 10-fold
higher than what was observed in the eYFPVE-cadherin+ pop-
ulation; Figure S5B). These results indicate that the hematopoi-
etic potential of the E8.25 CHs is restricted to the VE-cadherin+
population and is enriched in its eYFP+ subpopulation. We next
performed explant cultures (Cumano et al., 1996) to examine
the B lymphoid potential, as described in Figure 5D. CD19+ B
cells were generated from 11 of the 20 fragments cultured
separately. Among the positive fragments, eYFP+ CD19+ BCell Reports 8, 3cells were derived from six fragments
(Table S1). Representative flow cyto-
metric plots are shown in Figure 5E.
These results demonstrate that the prog-
eny of E7.5 Runx1+ cells in the E8.25
CHs have B lymphoid potential. Based
on these findings, we conclude thateYFP+VE-cadherin+ cells in E8.25 DAs have definitive hemato-
poietic potential.
Combinedwith the evidence that Runx1 labeling at E7.5marks
the hemogenic endothelium of the DA and HSCs, these results
suggest that some of the progeny of the E7.5 Runx1+ cells in
the CHs at E8.25 contribute to the precursors of HSCs. Due to
the angioblastic character and hemogenic potential of these
migrating cells, we named them ‘‘hemogenic angioblasts.’’
DISCUSSION
Here, we provide evidence of a circulation-independent dif-
ferentiation pathway from the E7.5 extraembryonic mesoderm
toward HSCs via hemogenic angioblasts. In this model, E7.5
Runx1+Gata1 cells contribute to the HSC lineage via hemo-
genic endothelium by migrating to intraembryonic sites prior to
establishment of the circulatory system. By contrast, E7.5
Runx1+Gata1+ cells predominantly contribute to the primitive
erythrocyte lineage and move to intraembryonic sites after
establishment of the circulatory system.
In this study, we were unable to clearly identify the location of
E7.5 Runx1+Gata1 cells. However, several lines of evidence
indicate that E7.5 Runx1+Gata1 cells should be located near
the boundary, such as in the amnion and allantois, but not in
the BIs. First, Runx1 expression is detected in the BIs, chorionic
mesoderm, allantois, and YS visceral endoderm in E7.5 embryos
(Daane and Downs, 2011; Iacovino et al., 2011; Lacaud et al.,
2002; North et al., 1999; Zeigler et al., 2006), whereas Gata1
expression is seen in the BIs and extraembryonic ectoderm
(Ema et al., 2006; Onodera et al., 1997; Silver and Palis, 1997;
Yokomizo et al., 2007). Second, only Flk1-GFP+ cells around
the boundary migrated to the intraembryonic region. Third, no
Runx1-GFP+ cells in the BIs moved. Finally, hemogenic angio-
blasts were first detected around the boundary 8 hr after 4OHT
induction.
This circulation-independent pathway tells us that the circula-
tion is not the only possible route by which HSC precursors can
migrate before hemogenic vessels are established. However,
circulation is clearly still a factor that confounds analysis of the1–39, July 10, 2014 ª2014 The Authors 35
Figure 4. Time-Lapse Images of the Movement of the Progeny of E7.5 Runx1+ Cells
(A) GFP images of the posterior orientation view of E7.5 Flk1GFP/+ embryo before cultured (left) and after (right).
(B) A differential interference contrast (DIC) image of an E7.5Runx1IRESGFP/+ embryo (left) and a GFP image of the higher magnification of the BI region highlighted
by the dotted box in the DIC image (right).
(C and D) eYFP images and DIC images overlaid on eYFP images of Z sections focusing on intraembryonic region (C) and BIs (D) from the same XY orientation of
the same embryo.
(E) Contribution of eYFP+ cells to the DA. Time 0:00 (T0): a DIC image overlaid on the eYFP image of Z sections and the eYFP image focusing on the boundary
between the extra- and intraembryonic regions. eYFP+ cells were detected in the BIs and the boundary region (pink arrows). T0 + 2–4 hr: eYFP images. The eYFP
+
cells from the boundary region (pink arrows) moved into the intraembryonic region and divided during the migration. T0 + 6–7 hr: eYFP images. The eYFP
+ cells
(pink arrows) started to form an endothelial layer. T0 + 8 hr: a DIC image overlaid on the eYFP image of Z sections and the eYFP image. The eYFP
+ cells (pink
arrows) contributed to DA endothelium (pink dotted lines). A higher-magnification image of the eYFP+ endothelium is in the white box. These images are
snapshots of Movies S1 (A), S2 (B), and S3 (C–E). BI, blood islands; AL, allantois; YV, yolk sac vasculature; DA, dorsal aorta; H, head; EX, extraembryonic; IN,
intraembryonic. Scale bars, 100 mm.
See also Figure S4.
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Figure 5. The Progeny of E7.5 Runx1+ Cells Contribute to DA Endothelium before Circulation Starts and Have Definitive Hematopoietic
Potential
(A) Whole-mount immunostaining of eYFP, CD31, and Runx1 in E8.25 Runx1SACre/+::R26ReYFP/+ embryos labeled at E7.5. Higher-magnification views of the DA
region (dotted boxes) in merged images are shown at the bottom. Scale bars, 200 mm.
(B) X-gal staining of posterior paired DA from E8.0 Runx1SACre/+::R26RLacZ/+ embryos labeled at E7.5. Scale bar, 100 mm.
(C) Immunostaining of eYFP and VE-cadherin in posterior paired DA from E8.25Runx1SACre/+::R26ReYFP/+ embryos labeled at E7.5. VA, vitellin artery; HD, hindgut
diverticulum. Scale bars, 100 mm.
(D) Experimental design of the B cell potential assay for the progeny of E7.5 Runx1+ cells in the caudal halves (CHs). Each CHwas subjected to a two-step culture.
(E) Flow cytometric analysis of the 14-day B cell induction cultures of the CHs for eYFP, CD45, CD19, and Mac1.
See also Figure S5 and Table S1.origin of HSCs after they emerge from the hemogenic endo-
thelium. The circulation-independent pathway also fits with all
previous reports concerning the sites of HSC generation at the
precirculation stage and in no-circulation models. Hemogenic
potential is equivalently detected in E8.25 head and CHs
(Li et al., 2012). Lymphoid potential is independently detectedin the placenta, YS, and CH in E8.5–E9.5 Ncx-1/ embryos
that lack circulation (Li et al., 2012; Rhodes et al., 2008; Yoshi-
moto et al., 2011, 2012). Tracing of the lateral-plate mesoderm
using the HoxB6-Cre mouse line shows that all hemogenic
endothelial beds share the same mesodermal origin (Zovein
et al., 2010). HoxB6-Cre expression is first detected in the E7.5Cell Reports 8, 31–39, July 10, 2014 ª2014 The Authors 37
extraembryonic mesoderm (Lowe et al., 2000). All of these data
support our conclusion that all hemogenic endothelial cells are of
E7.5 extraembryonic origin.
Runx1 expression in E7.5 Runx1+Gata1 cells is transient and
is downregulated upon migration into the embryo proper. Runx1
is reinduced around E8.5–9.5, at least in some ‘‘Runx1-primed
angioblasts’’ after their integration into the intraembryonic
vascular system. Thus, Runx1 is likely to play a distinct role at
each stage. The first stage involves E7.0–7.5 Runx1+Gata1
cells and the second stage involves E8.5–10.5 ECs. Our fate
analysis and the time-controlled restoration experiment of
Runx1 gene indicated that Runx1 expression in E7.5 Runx1+
Gata1 cells is required for HSC development (Tanaka et al.,
2012). The requirement for Runx1 in the establishment or differ-
entiation of BL-CFCs in the embryonic stem cell (ESC) differen-
tiation system also indicates its importance at this early stage
(E6.5–E7.5) for HSC generation (Lacaud et al., 2002). Given
that the immediate fate of E7.5 Runx1+Gata1 cells is the angio-
blast rather than the hematopoietic lineage, Runx1 may be
involved in generating a memory-like state in this context. This
state should be maintained even after the downregulation of
Runx1 in the angioblasts. This early role appears to be essential
for conferring the potential to give rise to definitive HSCs at the
later stage while preserving the EC fate, perhaps by its novel
function of unfolding chromatin (Hoogenkamp et al., 2009).
How transient expression of Runx1 at E7.5 generates such a
memory state is an important question for future studies, and
is distinct from the question of Runx1’s activity in the later hemo-
genic EC stage, which is not addressed here.
The possibility that Runx1 plays a role in two distinct
stages during HSC differentiation requires reconsideration of
the long-standing conundrum concerning Runx1 haploinsuffi-
ciency. Runx1 haploinsufficiency affects the localization of
definitive HSCs at E10.5 (Cai et al., 2000) and accelerates
mesoderm development in ESC differentiation (Lacaud et al.,
2004). These observations suggest that the Runx1 dosage in-
fluences the differentiation process. Ultimately, of course, an
explanation for this phenomenon will require an exact under-
standing of the genes that are directly regulated by Runx1
expression. In this study, the Runx1SACre/+ and Runx1LacZ//+
mouse lines were haploinsufficient, but the Runx1IRESGFP/+
mouse line was not. Our study stresses the necessity of inves-
tigating the role of Runx1 in two separate processes, i.e.,
the acquisition of hemogenic potential and the EC-to-HSC
transition. Runx1 was not essential for migration into the
embryo proper (data not shown). Moreover, the expression
level of Runx1 did not differ much between E7.5 Runx1+/+
and Runx1LacZ/+ embryos (data not shown). Thus, we speculate
that the Runx1 gene dosage does not significantly affect the
E7.5 stage. In fact, hemogenic angioblasts were generated in
the heterozygous embryo and contributed to definitive HSCs.
Considering the stage at which the phenotype of Runx1
haploinsufficiency is detected, we further speculate that this
phenomenon has more to do with the role of Runx1 in the
EC-to-BC transition. We show here that Runx1-labeled ECs
are present in both the YS and the embryo proper in Runx1
haploinsufficient embryos. Hence, it is likely that the decrease
in Runx1 gene dosage significantly enhances the generation of38 Cell Reports 8, 31–39, July 10, 2014 ª2014 The AuthorsHSCs from hemogenic ECs in the YS, but delays the genera-
tion of HSCs from ECs in the embryo.
Several questions remain to be addressed in future studies.
First, we were unable to identify the exact location of E7.5
Runx1+Gata1 cells’ emergence or show their direct contri-
bution to HSCs, because of a lack of specific markers for this
population. Second, given that we undertook cell-tracing exper-
iments in Runx1 heterozygous mice but identified the two E7.5
Runx1+ populations in Runx1 wild-type mice, we cannot be
certain that these Runx1+ populations are exactly the same.
In conclusion, we have defined a continuous differentiation
trajectory of E7.5 Runx1+ hemogenic angioblasts to HSCs via
the hemogenic endothelium. We would like to emphasize that
this model of HSC generation does not exclude the possibility
that the same events may occur in other hemogenic tissues.
Although the precise spatiotemporal location of Runx1 expres-
sion at E7.5 remains to be determined, its expression in
Etv2+Flk1+ cells is essential for HSC formation, and entry of
the generated hemogenic angioblasts into the embryo proper
does not necessarily require systemic circulation.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in Supplemental Experimental
Procedures.
Mice
The targeting vector for the mouse Gata1 locus was constructed as shown
in Figure S2A. All animal experiments were carried out in accordance with
the RIKEN guidelines for animal and recombinant DNA experiments.
In Situ Hybridization
In situ hybridization for the analysis of Cre and Runx1 expression in mouse
embryos was performed as described previously (Kataoka et al., 2011).
X-Gal Staining
Whole-mount X-gal staining was performed as described previously (Tanaka
et al., 2012).
Cell and Organ Culture
For analysis of the B cell potential, CHs from E8.25 embryos after 4OHT injec-
tion on E7.5 were cultured as described previously (Tanaka et al., 2012).
Immunohistochemistry
Immunostainingwas performed as described previously (Yokomizo et al., 2007).
Flow Cytometry Analysis
Fluorescence-activated cell sorting analysis was performed using a BD
FACSAriaII (BD Biosciences). The antibodies used are listed in Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, one table, and three movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2014.05.055.
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